Vestal Point Capital, LP Portfolio Holdings
Vestal Point Capital, LP
- $2.21 Trillion
- Q3 2025
Vestal Point Capital, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $2.21 Trillion distributed in 81 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $119B, Arcellx, Inc. with a value of $103B, Nuvalent, Inc. with a value of $95.1B, Abivax Sa with a value of $84.9B, and Alcon Inc with a value of $82B.
Examining the 13F form we can see an increase of $315B in the current position value, from $1.9T to 2.21T.
Vestal Point Capital, LP is based out at New York, NY
Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.